APA (7th ed.) Citation

JJ, G., PW, M., K, L., MB, S., JS, S., RA, E., . . . TR, H. (2023). Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas. Journal of neuroendocrinology, 35(5), e13283. https://doi.org/10.1111/jne.13283

Chicago Style (17th ed.) Citation

JJ, Gile, McGarrah PW, Leventakos K, Sonbol MB, Starr JS, Eiring RA, Hobday TJ, and Halfdanarson TR. "Efficacy of First-line Checkpoint Inhibitors in Combination with Chemotherapy in High-grade Extrapulmonary Metastatic Neuroendocrine Carcinomas." Journal of Neuroendocrinology 35, no. 5 (2023): e13283. https://doi.org/10.1111/jne.13283.

MLA (9th ed.) Citation

JJ, Gile, et al. "Efficacy of First-line Checkpoint Inhibitors in Combination with Chemotherapy in High-grade Extrapulmonary Metastatic Neuroendocrine Carcinomas." Journal of Neuroendocrinology, vol. 35, no. 5, 2023, p. e13283, https://doi.org/10.1111/jne.13283.